Glaucoma Eye Drops Market, by Drug Type, by Disease Indication, By Distribution Channel, by Composition, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

Glaucoma may occur among the people with or without diabetes. Moreover, people with diabetic retinopathy have an increased risk of glaucoma. The condition is associated with abnormal blood vessel growth, which can result in retinopathy and leads to blockage of natural drainage of the eye. Rapidly increasing geriatric population is one of the important factors for increasing prevalence of glaucoma, which in turn is projected to drive growth of the glaucoma therapeutics market in near future. For instance, according to the International Diabetes Foundation (IDF) 2017 statistics, the number of people with diabetes aged between 20 to 79 years are increasing worldwide.

Market Dynamics

The global glaucoma eye drops market is expected to witness significant growth during the forecast period owing to the increasing prevalence of glaucoma, For instance, according to the International Agency for the Prevention of Blindness, in 2015, an estimated 3 million people suffered from blindness due to glaucoma in the U.S. Furthermore, as per the same source, it is estimated that by 2020 around 80 million people will suffer from glaucoma, with an increase of about 20 million from 2010 globally.

Key features of the study:

This report provides in-depth analysis of the global glaucoma eye drops market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global glaucoma eye drops market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Merck & Co., Inc., Allergan Plc., Novartis AG., Teva Pharmaceutical Industry, Pfizer, Inc., Bausch & Lomb Inc., Inotek Pharmaceutical, Jadran-galenski laboratorij d.d., Aerie Pharmaceutical, and Mylan N.V.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, government initiatives, technological upgradation, market expansion, and marketing tactics
The global glaucoma eye drops market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for glaucoma eye drops, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

Global Glaucoma Eye Drops Market, By Drug Type:
- Prostaglandin analogs
- Beta blockers
- Alpha agonists
- Carbonic Anhydrase Inhibitors (CAIs)
- Combined Medications
- Others (rho-kinase inhibitor, Cholinergic agonist)
Global Glaucoma Eye Drops Market, By Disease Indication:
- Angle-closure Glaucoma
- Open-angle Glaucoma
Global Glaucoma Eye Drops Market, By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Glaucoma Eye Drops Market, By Composition:
- Preservative Free
- BAK-Based
- Non BAK-Based Preservatives
Global Glaucoma Eye Drops Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
  - By Drug Type:
- Prostaglandin analogs
- Beta blockers
- Alpha agonists
- Carbonic Anhydrase Inhibitors (CAIs)
- Combined Medications
- Others (rho-kinase inhibitor, Cholinergic agonist)
  - By Disease Indication:
- Angle-closure Glaucoma
- Open-angle Glaucoma
  - By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
  - By Composition:
- Preservative Free
- BAK-Based
- Non BAK-Based Preservatives
- Europe
  - By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
  - By Drug Type:
- Prostaglandin analogs
- Beta blockers
- Alpha agonists
- Carbonic Anhydrase Inhibitors (CAIs)
- Combined Medications
- Others (rho-kinase inhibitor, Cholinergic agonist)
  - By Disease Indication:
- Angle-closure Glaucoma
- Open-angle Glaucoma
  - By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
  - By Composition:
- Preservative Free
- BAK-Based
- Non BAK-Based Preservatives
- Asia Pacific
  - By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
  - By Drug Type:
- Prostaglandin analogs
- Beta blockers
- Alpha agonists
- Carbonic Anhydrase Inhibitors (CAIs)
- Combined Medications
- Others (rho-kinase inhibitor, Cholinergic agonist)
  - By Disease Indication:
- Angle-closure Glaucoma
- Open-angle Glaucoma
  - By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
  - By Composition:
- Preservative Free
- BAK-Based
- Non BAK-Based Preservatives
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
  - By Drug Type:
- Prostaglandin analogs
- Beta blockers
- Alpha agonists
- Carbonic Anhydrase Inhibitors (CAIs)
- Combined Medications
- Others (rho-kinase inhibitor, Cholinergic agonist)
  - By Disease Indication:
- Angle-closure Glaucoma
- Open-angle Glaucoma
  - By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
  - By Composition:
- Preservative Free
- BAK-Based
- Non BAK-Based Preservatives
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
  - By Drug Type:
- Prostaglandin analogs
- Beta blockers
- Alpha agonists
- Carbonic Anhydrase Inhibitors (CAIs)
- Combined Medications
- Others (rho-kinase inhibitor, Cholinergic agonist)
  - By Disease Indication:
- Angle-closure Glaucoma
- Open-angle Glaucoma
  - By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
  - By Composition:
- Preservative Free
- BAK-Based
- Non BAK-Based Preservatives
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
  - By Drug Type:
- Prostaglandin analogs
- Beta blockers
- Alpha agonists
- Carbonic Anhydrase Inhibitors (CAIs)
- Combined Medications
- Others (rho-kinase inhibitor, Cholinergic agonist)
  - By Disease Indication:
- Angle-closure Glaucoma
- Open-angle Glaucoma
  - By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
  - By Composition:
- Preservative Free
- BAK-Based
- Non BAK-Based Preservatives
Company Profiles
- Merck & Co., Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Allergan Plc.
- Novartis AG
- Teva Pharmaceutical Industry
- Pfizer, Inc.
- Bausch & Lomb Inc.
- Inotek Pharmaceutical
- Jadran-galenski laboratorij d.d.
- Aerie Pharmaceutical
- Mylan N.V

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI3984

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Disease Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Composition
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Regulatory Scenario
Pipeline Analysis
Product Approvals
Product Launches
Pest Analysis
Pricing Analysis
Preservative and preservative-free glaucoma treatment solutions

4. Impact Analysis of Covid-19

Supply side Analysis
Demand Side Analysis
Impact on Healthcare Industry

5. Global Glaucoma Eye Drops Market, By Drug Type, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Prostaglandin analogs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Beta blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Alpha agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Carbonic Anhydrase Inhibitors (CAIs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Combined Medications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Others (rho-kinase inhibitor, Cholinergic agonist)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Glaucoma Eye Drops Market, By Disease Indication, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Angle-closure Glaucoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Open-angle Glaucoma
- Introduction
- Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Glaucoma Eye Drops Market, By Distribution Channel , 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Glaucoma Eye Drops Market, By Composition, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Preservative Free
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
BAK-Based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Non BAK-Based Preservatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

9. Global Glaucoma Eye Drops Market, By Region, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
- Regional Trends
North America
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel , 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Composition, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.S.
- Canada
Europe
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel , 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Composition, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel , 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Composition, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel , 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Composition, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Africa
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel , 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Composition, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
- North Africa
- Central Africa
- South Africa
Middle East
- Market Size and Forecast, By Drug Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Disease Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel , 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Composition, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- GCC
- Israel
- Rest of Middle East

10. Competitive Landscape

Company Profiles
- Merck & Co., Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Allergan Plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Teva Pharmaceutical Industry
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Bausch & Lomb Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Inotek Pharmaceutical
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Jadran-galenski laboratorij d.d.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Aerie Pharmaceutical
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Mylan N.V
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies

11. Section

References
Research Methodology
About us and Sales Contact

Glaucoma Eye Drops Market, by Drug Type, by Disease Indication, By Distribution Channel, by Composition, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028